eoadjuvant chemotherapy using the TXL and CDDP followed by surgery for advanced gastric cancer - Phase II
Not Applicable
- Conditions
- advanced gastric cancer
- Registration Number
- JPRN-C000000278
- Lead Sponsor
- TC therapy for gastric cancer study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Serious complications 2) Active multiple cancer 3) Obvious infection or acute inflammatory condition 4) Under treatment with systemic steroid 5) Probable pregnancy, and the period of lactation 6) Difficulty to join the trial due to psychosis or psychotic symptoms 7) Allergy to drugs containing Cremophor EL (including cyclosporin) 8) History of severe drug allergic reaction 9) History of alcoholic allergic reaction 10) Peripheral neuropathy 11) Not fit to the protocol treatment by the physicion's dicision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pathorogical response rate for all eligibility population
- Secondary Outcome Measures
Name Time Method three year survival rate, pathorogical response rate for patients who completed the protocol treatment, the proportion of complete resection, the proportion of patients who completed the protocol treatment, response rate of neoadjuvant chemotherapy, adverse event